ADMA ADMA Biologics, Inc.

ADMA ADMA Biologics, Inc.

Healthcare · Biotechnology

Market read

Scan convergence 2 scans as of 2026-10-16 2 neutral converging

POC $8.59 · VWAP $11.77 · -9.3% vs 12m avg buyer

downtrend vol: compressedgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

Watchlists @biotech

ADMA Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ADMA belongs to, members best 30-day change first — ADMA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings ADMA reports in 18 days Nov 4

Against street estimates

How ADMA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 0.160.17+3.5%Beat
May 6 0.200.17-15.3%Miss
Feb 25 0.200.22+7.8%Beat
Nov 5 '25 0.160.16+2.6%Beat
Aug 6 '25 0.140.14+7.4%Beat
May 7 '25 0.170.11-33.3%Miss
Mar 3 '25 0.150.14-9.3%Miss
Nov 7 '24 0.130.15+15.4%Beat